OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214

T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92

SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49

The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
Andrea Antinori, Mary T. Bausch-Jurken
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S4-S12
Open Access | Times Cited: 44

T‐cell activation–induced marker assays in health and disease
Chad Poloni, Cole Schonhofer, Sabine Ivison, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 491-503
Open Access | Times Cited: 42

Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans
Shirin Kalimuddin, C Tham, Yvonne Fu Zi Chan, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 2

A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100793-100793
Open Access | Times Cited: 54

COVID-19 disease and immune dysregulation
Ethan Davitt, Colin Davitt, Monty B. Mazer, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101401-101401
Open Access | Times Cited: 50

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37

Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
Joseph Yunis, Kirsty R. Short, Di Yu
Trends in Microbiology (2023) Vol. 31, Iss. 6, pp. 644-656
Open Access | Times Cited: 26

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study
Li Guo, Qiao Zhang, Xiaoying Gu, et al.
The Lancet Microbe (2023) Vol. 5, Iss. 1, pp. e24-e33
Open Access | Times Cited: 25

First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody
Negar Omidvari, Terry Jones, Pat Price, et al.
Science Advances (2023) Vol. 9, Iss. 41
Open Access | Times Cited: 22

Multimodal single-cell datasets characterize antigen-specific CD8+ T cells across SARS-CoV-2 vaccination and infection
Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1725-1734
Open Access | Times Cited: 21

Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study
Aric A. Prather, Ethan G. Dutcher, James E. Robinson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19

Hybrid and herd immunity 6 months after SARS-CoV-2 exposure among individuals from a community treatment program
Parawee Chevaisrakul, Putthapoom Lumjiaktase, Pongtorn Kietdumrongwong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17

Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 15

A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
Antonio Bertoletti, Martin Qui, Joey Ming Er Lim
Elsevier eBooks (2025), pp. 191-206
Closed Access

NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery
Inka Sastalla, Keehwan Kwon, Clayton C. Huntley, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 87-87
Open Access

Analysis of the immune response in COVID-19
Altijana Hromić‐Jahjefendić, Alaa A. A. Aljabali
Progress in molecular biology and translational science (2025)
Closed Access

Page 1 - Next Page

Scroll to top